Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months

Ulcerative colitis (UC) is a chronic inflammatory bowel disease with recurrent episodes of debilitating symptoms negatively affecting work productivity and health-related quality of life (HRQoL). The use of bi...

Source: BMC Gastroenterology - April 12, 2021 Category: Gastroenterology Authors: Niels Teich, Harald Gr ümmer, Eric Jörgensen, Thomas Liceni, Frank Holtkamp-Endemann, Tim Fischer and Susanne Hohenberger Tags: Research article Source Type: research